Show simple item record

dc.contributor.authorBaylis, Sally Aen
dc.contributor.authorGerlish, Wen
dc.contributor.authorChudy, Men
dc.contributor.authorPisani, Gen
dc.contributor.authorKlotz, Aen
dc.contributor.authorKerby, Sen
dc.contributor.authorHeath, Aen
dc.contributor.authorWorld Health Organization. Biologicals Uniten
dc.contributor.authorWHO Expert Committee on Biological Standardization (‎2006 : Geneva, Switzerland)‎en
dc.coverage.spatialGeneva
dc.date.accessioned2012-06-17T01:33:20Z
dc.date.available2012-06-17T01:33:20Z
dc.date.created2006en
dc.date.issued2006en
dc.identifier.govdocWHO/BS/06.2034en
dc.identifier.urihttp://www.who.int/iris/handle/10665/69957
dc.descriptionWHO/BS/06.2034en
dc.description23 p.en
dc.descriptionEnglish onlyen
dc.language.isoenen
dc.publisherWorld Health Organization
dc.publisherWorld Health Organization
dc.subject.otherPharmaceuticals and Biologicalsen
dc.titleWHO collaborative study to establish a replacement WHO international standard for hepatitis B virus DNA nucleic acid amplification technology (‎NAT)‎ assays / by Sally A. Baylis, W. Gerlish, M. Chudy, G. Pisani, A. Klotz, S. Kerby, and A. Heathen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record